These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27357179)

  • 21. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
    Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B; Lobsien D; Kahn T; Stumpp P
    PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.
    Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
    BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of false-positive lesions in evaluating colorectal liver metastases on gadoxetic acid-enhanced magnetic resonance imaging.
    Yamada S; Kishi Y; Miyake M; Nara S; Esaki M; Shimada K
    Surg Today; 2022 Aug; 52(8):1178-1184. PubMed ID: 35043218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
    Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
    Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the link between quantitative biexponential diffusion-weighted imaging and contrast-enhanced MRI in the liver.
    Dijkstra H; Oudkerk M; Kappert P; Sijens PE
    Magn Reson Imaging; 2017 May; 38():47-53. PubMed ID: 27993534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.
    Vreugdenburg TD; Ma N; Duncan JK; Riitano D; Cameron AL; Maddern GJ
    Int J Colorectal Dis; 2016 Nov; 31(11):1739-1749. PubMed ID: 27682648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
    Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
    Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging.
    Löwenthal D; Zeile M; Lim WY; Wybranski C; Fischbach F; Wieners G; Pech M; Kropf S; Ricke J; Dudeck O
    Eur Radiol; 2011 Apr; 21(4):832-40. PubMed ID: 20886339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
    Oba A; Mise Y; Ito H; Hiratsuka M; Inoue Y; Ishizawa T; Arita J; Matsueda K; Takahashi Y; Saiura A
    HPB (Oxford); 2018 Aug; 20(8):708-714. PubMed ID: 29534862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
    Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI.
    Colagrande S; Castellani A; Nardi C; Lorini C; Calistri L; Filippone A
    Eur J Radiol; 2016 May; 85(5):1027-34. PubMed ID: 27130067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.
    Liu HF; Xu YS; Liu Z; Che KY; Sheng Y; Ding JL; Zhang JG; Lei JQ; Xing W
    Acad Radiol; 2021 Jun; 28(6):790-798. PubMed ID: 32414638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative detection of colorectal liver metastases: DWI alone or combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI.
    Schulz A; Joelsen-Hatlehol ES; Brudvik KW; Aasand KK; Hanekamp B; Viktil E; Johansen CK; Dormagen JB
    Acta Radiol; 2020 Mar; 61(3):302-311. PubMed ID: 31335157
    [No Abstract]   [Full Text] [Related]  

  • 37. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
    Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB
    World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the DWI and Gd-EOB-DTPA-enhanced MRI on assessing the hepatic ischemia and reperfusion injury after partial hepatectomy.
    Lu Y; Liu P; Fu P; Chen Y; Nan D; Yang X
    Biomed Pharmacother; 2017 Feb; 86():118-126. PubMed ID: 27951418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.